Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Boscaro

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
F1000 Medicine Reports|October 16, 2010
New treatment guidelines on Cushing's diseaseGiorgio Arnaldi, Marco Boscaro
Expert Opinion on Investigational Drugs|June 11, 2010
Pasireotide for the treatment of Cushing's diseaseGiorgio Arnaldi, Marco Boscaro
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 11, 2016
Cushing's Syndrome: Screening and DiagnosisFilippo Ceccato, Marco Boscaro
The Journal of Clinical Endocrinology and Metabolism|September 8, 2009
Approach to the patient with possible Cushing's syndromeMarco Boscaro, Giorgio Arnaldi
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Adrenal incidentalomaGiorgio Arnaldi, Marco Boscaro
Treatments in Endocrinology|March 24, 2005
Pharmacologic management of Cushing syndrome : new targets for therapyNicoletta Sonino, Marco Boscaro, Francesco Fallo
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 11, 2005
[Endocrinology of aldosterone]Vanessa Ronconi, Gilberta Giacchetti, Marco Boscaro
Therapeutics and Clinical Risk Management|April 3, 2015
Clinical use of pasireotide for Cushing's disease in adultsFilippo Ceccato, Carla Scaroni, Marco Boscaro
Endocrine|November 28, 2013
Harmful effects of functional hypercortisolism: a working hypothesisGiacomo Tirabassi, Marco Boscaro, Giorgio Arnaldi
Annals of the New York Academy of Sciences|July 19, 2012
Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterationsMarco Boscaro, Gilberta Giacchetti, Vanessa Ronconi
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
F1000 Medicine Reports|October 16, 2010
New treatment guidelines on Cushing's diseaseGiorgio Arnaldi, Marco Boscaro
Expert Opinion on Investigational Drugs|June 11, 2010
Pasireotide for the treatment of Cushing's diseaseGiorgio Arnaldi, Marco Boscaro
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 11, 2016
Cushing's Syndrome: Screening and DiagnosisFilippo Ceccato, Marco Boscaro
The Journal of Clinical Endocrinology and Metabolism|September 8, 2009
Approach to the patient with possible Cushing's syndromeMarco Boscaro, Giorgio Arnaldi
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Adrenal incidentalomaGiorgio Arnaldi, Marco Boscaro
Treatments in Endocrinology|March 24, 2005
Pharmacologic management of Cushing syndrome : new targets for therapyNicoletta Sonino, Marco Boscaro, Francesco Fallo
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 11, 2005
[Endocrinology of aldosterone]Vanessa Ronconi, Gilberta Giacchetti, Marco Boscaro
Therapeutics and Clinical Risk Management|April 3, 2015
Clinical use of pasireotide for Cushing's disease in adultsFilippo Ceccato, Carla Scaroni, Marco Boscaro
Endocrine|November 28, 2013
Harmful effects of functional hypercortisolism: a working hypothesisGiacomo Tirabassi, Marco Boscaro, Giorgio Arnaldi
Annals of the New York Academy of Sciences|July 19, 2012
Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterationsMarco Boscaro, Gilberta Giacchetti, Vanessa Ronconi
Pageof 16